"Pioneers for sustainable health: Das Fraunhofer-Institut für Toxikologie und Experimentelle Medizin ITEM ist eines von über 70 Instituten der Fraunhofer-Gesellschaft, der größten Organisation für anwendungsorientierte Forschung in Europa. Ziele der Auftragsforschung am Fraunhofer ITEM sind es, den Menschen in unserer industrialisierten Welt vor gesundheitlicher Gefährdung zu schützen und an der Entwicklung neuer therapeutischer Ansätze mitzuwirken. Mit Schwerpunkt auf der Atemwegsforschung umfasst das FuE-Portfolio drei Geschäftsfelder: die Arzneimittelentwicklung, die Chemikalienbewertung sowie die translationale Medizintechnik."

During the past decade, Fraunhofer ITEM conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 2 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fraunhofer ITEM" #1 collaborator was "German Research Foundation" with 3 trials as a collaborator, "Hannover Medical School" with 3 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator, "Institute for Pharmacology and Toxicology, RWTH Aachen" with 1 trials as a collaborator and "M et P Pharma AG" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Fraunhofer ITEM" are "Healthy" (7 trials), "Asthma" (5 trials), "Chronic Obstructive Pulmonary Disease" (2 trials), "Healthy Subjects" (2 trials) and "Pulmonary Disease, Chronic Obstructive" (2 trials). Many other conditions were trialed in "Fraunhofer ITEM" in a lesser frequency.

Most popular intervention types in "Fraunhofer ITEM" are "Drug" (10 trials), "Other" (9 trials), "Procedure" (6 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Bronchoscopy" (4 trials), "BI 1026706" (2 trials), "'Eucerin AtopiControl Lotion' (for the body)" (1 trials) and "ACC" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fraunhofer ITEM" are 23 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Fraunhofer ITEM". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Fraunhofer ITEM, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Fraunhofer ITEM, 6 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 15 trials that are defined as “Not Applicable".